Holen Sie sich die Stockscreener-App
1.88
11.24%
0.19
Cerenome, Inc. Common Stock Aktie (CNSY) Neueste Nachrichten
New Strong Sell Stocks for October 15th - Zacks Investment Research
Form 4 Cerenome, Inc For: 1 October By Investing.com - Investing.com Canada
Form 4 Cerenome, Inc For: 1 October - Investing.com India
Form 4 Cerenome, Inc For: 1 October By Investing.com - Investing.com UK
After stock grant vesting, Cerenome (CNSY) director Kyle Guse holds 1,843 shares directly. - Stock Titan
Three stock grants vest, giving Cerenome (CNSY)'s CFO 2,985 common shares. - Stock Titan
After acquiring 921 shares, Cerenome (CNSY) director holds 1,843 shares directly. - Stock Titan
Three stock grants vest as Cerenome (CNSY) CEO Hedrick acquires 6,387, 8,066 and 1,986 shares. - Stock Titan
A director acquires 921 shares as Cerenome (CNSY) stock grants vest, bringing direct holdings to 1,843. - Stock Titan
A stock grant vests at Cerenome (CNSY). Director Hawkins acquires 921 shares and holds 2,450 common shares. - Stock Titan
Form 4 Cerenome, Inc For: 1 October By Investing.com - Investing.com South Africa
Cerenome, Inc. (CNSY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cerenome, Inc. (CNSY) stock price, news, quote and history - Yahoo Finance UK
Cerenome plans to discuss billing and access for its spinal-fluid diagnostic platform. - Stock Titan
ServiceNow To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Cerenome forecasts its cash will last into 2028 with new financing - Stock Titan
Cerenome, Inc. announced that it expects to receive $20 million in funding from 3i Fund - marketscreener.com
Cerenome Launches New Corporate Identity As Integrated CNS Oncology Company | News - Voice of Alexandria
CNSY | Cerenome, Inc. Common Stock Stock Data, Price & News - Quiver Quantitative
Cerenome Reports Second Quarter 2026 Financial Results and Business Update - The Manila Times
What is the current Price Target and Forecast for Cerenome, Inc. (CNSY) - Zacks Investment Research
Cerenome, Inc. Stock (CNSY)Quote Nasdaq - marketscreener.com
CNSY Forecast — Price Target — Prediction for 2027 - TradingView
Cerenome (Nasdaq:CNSY)주식 분석 - simplywall.st
Cerenome (Nasdaq:CNSY)Stock Analysis - Simply Wall Street
CNSY Stock Price and Chart — NASDAQ:CNSY - tradingview.com
CNSYCerenome Inc Stock Price and Quote - Finviz
Plus Therapeutics, Inc. will Change its Ticker to CNSY from PSTV - marketscreener.com
Cerenome will combine CNS cancer diagnostics, treatments and AI Aug. 3 - Stock Titan
Cerenome Launches as an Integrated CNS Oncology Company - GlobeNewswire
Cerenome Launches as an Integrated CNS Oncology Company - Yahoo Finance
Plus Therapeutics' CNSide Tests Influenced Treatment Decisions in 90% of Cases - Stock Titan
Plus Therapeutics to rebrand as Cerenome and adopt CNSY ticker on August 3 (PSTV) - finance.yahoo.com
Plus Therapeutics to rebrand as Cerenome, change ticker to CNSY - Investing.com
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding - GlobeNewswire
Plus Therapeutics Reports First Quarter 2026 Financial - GlobeNewswire
Plus Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire
Plus Therapeutics taps ex-Kiora executive to help push CNS cancer pipeline - Stock Titan
To keep its Nasdaq listing, Plus Therapeutics enacts 1-for-25 split - Stock Titan
Plus Therapeutics Announces Reverse Stock Split - GlobeNewswire
Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Plus Therapeutics Reports 2025 Results, Business Progress - GlobeNewswire
HIND Stock Price and Chart — NASDAQ:HIND - TradingView
LTRN Stock Price and Chart — NASDAQ:LTRN - tradingview.com
PLUS THERAPEUTICS (PSTV) Stock Price, News & Analysis - Stock Titan
EGRX Stock Price and Chart — OTC:EGRX - TradingView
ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):